WHO says wider alert on contaminated J&J cough syrup ‘likely’

WHO says wider alert on contaminated J&J cough syrup ‘likely’

The World Health Organization is likely to issue a wider warning about contaminated Johnson and Johnson-made children’s cough syrup found in Nigeria last week, it said in an email. Nigeria’s regulator recalled a batch of Benylin syrup last Wednesday, having found a high level of diethylene glycol in the product during routine testing. The contaminant, … Read more

J&J expects COVID vaccine sales to jump as much as 46% in 2022

photo

Johnson & Johnson said on Tuesday it expects to generate as much as $3.5 billion from the sale of its COVID-19 vaccine this year compared to $2.39 billion in 2021, in a sign of easing manufacturing problems and increasing demand. Delivery delays and an uneven demand during last year resulted in the drugmaker narrowly missing … Read more

Johnson & Johnson plans to split into two companies

photo

Johnson & Johnson said on Friday that it is planning to break up into two companies, splitting off its consumer health division that sells Band-Aids and Baby Powder from its large pharmaceuticals unit. The healthcare company will separate its consumer health business into a new publicly traded company and is aiming to complete the planned … Read more

Johnson & Johnson Q1 profit, sales jump, beats Wall Street forecast

photo

Big jumps in sales of prescription drugs and medical devices helped Johnson & Johnson boost its first-quarter profit nearly 7%, blowing past Wall Street forecasts. The health care giant on Tuesday raised and narrowed its financial forecasts for 2021, and its shares jumped more than 2% in midday trading. The one weak spot was a … Read more

J&J Seeks Emergency Approval of COVID Vaccine

Feb. 5, 2021 — The world’s first single-dose COVID-19 vaccine, from Johnson & Johnson, has been submitted to the U.S. Food and Drug Administration for emergency use approval. Preliminary findings from a large international study suggest the vaccine isn’t quite as strong as the two current FDA-approved vaccines from Pfizer and Moderna, which are … Read more

Johnson & Johnson starts phase 3 trial of vaccine; could be available for use by early 2021

photo

Mumbai: US drug maker Johnson & Johnson on Wednesday announced the start its phase 3 trial of the Covid-19 vaccine, a move that would take the company closer to launch of the vaccine by end of this year. Start of phase 3 trial is the result of positive results from the company’s phase 1and 2 … Read more